Tuesday, September 9, 2025

Amigo & Eucalyptus Partner to Scale AI Telehealth Globally

Related stories

Cerence AI Brings Microsoft 365 Copilot to Cars for Work

Cerence, a global leader in conversational AI-powered user experiences,...

Smarsh Uses Salesforce Agentforce to Launch AI Support Agents

Smarsh, the global leader in communications data and intelligence,...

Redis to Acquire Decodable to Boost Real-Time Data Platform

Redis, the leading real-time data platform, announced its intention...

Ketryx Raises $39M Series B to Advance AI in Life Sciences

Ketryx, the AI-driven compliance platform that helps life sciences...

Snap Inc. Unveils Imagine Lens, Revolutionizing Creative Expression with AI

Snap Inc., the pioneer in camera technology and creative...
spot_imgspot_img

Strategic partnership aims to deploy AI health assistants across Australia’s largest telehealth platform serving 200,000+ patients in four countries.

Amigo, the AI infrastructure company building trustworthy agents for high-stakes environments, announced a strategic partnership with leading global telehealth provider Eucalyptus. The multi-year collaboration will integrate AI-powered health agents into Eucalyptus’s portfolio of specialized healthcare brands, beginning with the successful deployment of an AI health assistant for the company’s Juniper weight management clinic.

This partnership represents a significant step forward in addressing the critical challenge of staff shortages within the healthcare industry, where well-timed engagement often determines patient outcomes. By providing continuous, intelligent support, the AI health assistant helps maintain patient motivation and adherence to treatment plans while capturing valuable insights that inform clinical decision-making.

“We are committed to pioneering the future of digital healthcare,” said Benny Kleist, Co-Founder and Chief Strategy Officer of Eucalyptus. “Working with Amigo represents a significant step forward in our mission to make quality healthcare more accessible, allowing our clinical teams to ensure every patient receives the always-on, personalized support they need to achieve their health goals.”

Also Read: Hyperfine Launches Optive AI™ to Boost Swoop® Imaging

The initial success of June, achieving a <2% human escalation rate with 100% performance on clinical safety metrics in live deployment, establishes a new benchmark for AI care delivery and validates the potential for scaled deployment across multiple therapeutic areas.

Following this deployment, Amigo and Eucalyptus plan to expand AI-powered healthcare support across Eucalyptus’s broader network of specialized virtual clinics, each tailored to address specific therapeutic areas and patient populations.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img